Author

Prafulla Bhad

OpenAlex ID: A5021689008

Randomised clinical trial: significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoea

2020 · Michael Camilleri, Sara Linker Nord, et al. · Alimentary Pharmacology & Therapeutics · 45

Evaluation of Pharmacokinetic Interactions Between Amlodipine, Valsartan, and Hydrochlorothiazide in Patients With Hypertension

2010 · Prafulla Bhad, Surya Ayalasomayajula, et al. · The Journal of Clinical Pharmacology · 23

Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate‐release tablet formulation

2015 · Girish Bende, Shibadas Biswal, et al. · Clinical Pharmacology in Drug Development · 14

Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem®) for bioequivalence in a randomized, open-label, two-period study

2013 · Gilbert Lefèvre, Prafulla Bhad, et al. · Malaria Journal · 12

976 – A Double-Blind, Randomized, Placebo-Controlled, Crossover, Multiple-Dose Study of Tropifexor, a Non Bile Acid Fxr Agonist, in Patients with Primary Bile Acid Diarrhea

2019 · Michael Camilleri, Sara Linker Nord, et al. · Gastroenterology · 5

A Randomized Controlled Trial of a Farnesoid X Receptor Agonist, Tropifexor, in Patients with Primary Bile Acid Diarrhea

2020 · Michael Camilleri, Sara Linker Nord, et al. · The Novartis Repository (Novartis)

Works count: 7

Citation count: 99

H-index: 5

I10-index: 4